Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Hisamitsu Pharmaceutical Co., Inc. (4530)
Delisted
8 May 2026
JPX
All
(2)
TW
(1)
JP
(1)
JPX
Primary
TWSE
¥
6,040.
00
0
0%
¥
303.47B
Market Cap
-
P/E Ratio
0.76%
Div Yield
679,000
Volume
-
Eps
¥
6,040
Previous Close
Day Range
6,040
6,050
Year Range
3,861
6,695
Want to track
4530
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Statistics
Historical Data
Hisamitsu Pharmaceutical Co., Inc. (4530) Statistics
Valuation metrics
Market Cap
303.47B
Enterprise value
312.12B
Trailing P/E (ttm)
22.52
Forward P/E
27.5
PEG ratio
27.5
Price/Sales (ttm)
2.61
Price/Book (mrq)
1.46
Enterprise Value/Revenue
1.92
Enterprise Value/EBITDA
12.5
Overview
Shares outstanding
70.4M
Float
22.58M
Shares short
-
% Held by insiders
0.84%
% Held by institutions
0.31%
Average volume (10 days)
133.92K
Average volume (90 days)
253.39K
Price summary
52-Week low
3,861
52-Week high
6,695
Beta
0.28
50-Day moving average
6,101.36
200-Day moving average
4,868.18
Dividends and splits
Forward annual dividend rate
120
Forward annual dividend yield
0.0199%
Trailing annual dividend rate
105
Trailing annual dividend yield
0.0174%
5-Year annual dividend yield
2.05%
Payout ratio
0.17
Dividend Date
1 May 2026
Ex-Dividend Date
26 Feb 2026
Last split factor
-
Last split Date
-
Financials
Fiscal year
Fiscal year ends
28 Feb 2026
Most recent quarter (mrq)
31 May 2025
Profitability
Profit margin
0.12%
Operating margin
0.11%
Operational effectiveness
Return on assets
0.03%
Return on equity
0.07%
Income Statement
Revenue (ttm)
163.02B
Revenue per share (ttm)
2,284.98
Quarterly revenue growth (yoy)
0.08%
Gross profit (ttm)
96.12B
EBITDA
30.37B
Net income to common (ttm)
19.16B
Diluted EPS (ttm)
268.35
Quarterly earnings growth (yoy)
-0.1%
Balance Sheet
Total cash (mrq)
118.64B
Total cash per share (mrq)
1,685.16
Total debt (mrq)
2.38B
Total Debt/Equity (mrq)
0.81
Current ratio (mrq)
4.08%
Book value per share (mrq)
4,145.06
Cash Flow
Cash flow statement
17.48B
Levered free cash flow (LFCF)
1B